Evidence map›Paper›PMID 18752633›Full record

ArticleJournal of cellular and molecular medicine2009

Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens.

D Minardi, G Lucarini, A Filosa, G Milanese, A Zizzi, R Di Primio, R Montironi, G Muzzonigro

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Clinical Significance ofOncoTargets and therapy · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. The epigenetic landscape of clear-cell renal cell carcinoma.Journal of kidney cancer and VHL · 2015
    Article
  18. Article
  19. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

D MinardiInstitute of Maternal and Children's Sciences-Urology, Polytechnic University of the Marche Region - Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
G LucariniDepartment of Molecular Pathology and Innovative Therapies-Histology, Polytechnic University of the Marche Region, Ancona, Italy.
A FilosaInstitute of Pathological Anatomy, Polytechnic University of the Marche Region - Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
G MilaneseInstitute of Maternal and Children's Sciences-Urology, Polytechnic University of the Marche Region - Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
A ZizziDepartment of Molecular Pathology and Innovative Therapies-Histology, Polytechnic University of the Marche Region, Ancona, Italy.
R Di PrimioDepartment of Molecular Pathology and Innovative Therapies-Histology, Polytechnic University of the Marche Region, Ancona, Italy.
R MontironiInstitute of Pathological Anatomy, Polytechnic University of the Marche Region - Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
G MuzzonigroInstitute of Maternal and Children's Sciences-Urology, Polytechnic University of the Marche Region - Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
Marche Polytechnic University · ITAzienda Ospedaliero Universitaria Ospedali Riuniti · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgery is the main treatment for renal cell carcinoma (RCC); nephron sparing surgery can be performed as a treatment of choice for small peripheral lesions. Epigenetics configures a new entity that regulates gene expression throughout methylation, acetylation and chromatin remodelling. In addition to silencing as a result of mutations, loss of heterozygosity, or classic genetic events, epigenetic modification symbolizes essential events during carcinogenesis and tumour development. We investigated global methylation and histone acetylation expression in a series of small conventional clear cell renal carcinomas (i.e. less than 5 cm) (pT1a) treated with partial nephrectomy, to assess their possible role as diagnostic biomarkers. A total of 54 patients with conventional single RCC were selected and treated with partial nephrectomy; they were followed up to 186 months. Immunohistochemistry was performed on paraffin-embedded sections, using anti-5-methylcytosine (5mc) and anti-Acetyl-Histone H3 (Lys 9). Our results confirm that the mean percentage of global cellular methylation in tumoural tissue was significantly higher compared to healthy peritumoural tissue, whereas the mean percentage of histone cellular acetylation in tumoural tissue was significantly lower. The percentage of methylation was significantly higher in grades 3 and 4 (P = 0.033), whereas the percentage of histone acetylation was significantly lower (P = 0.023), suggesting therefore that these markers could correlate with tumour aggressiveness in pT1a RCC. On univariate analysis of patient survival in relation to the different considered factors, Fuhrman grade was the most important survival factor. These epigenetic markers can give us interesting information about chromatin remodelling in RCCs; the percentage of global methylation increases with increasing Fuhrman grade, whereas histone acetylation decreases with increasing grade in small RCC; our results suggest that global hypermethylation and histone hypoacetylation can be assumed to be an early event in RCC and to correlate with tumour aggressiveness.

Indexed as

DNA MethylationNephrectomyAcetylationAdultAgedFemaleHistonesHumansImmunohistochemistryKidney NeoplasmsMaleMiddle AgedPrognosisHistones

Identifiers

PMID18752633
PMCPMC6512382
OpenAlexW2092514089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.